Tecfidera (dimethyl fumarate) approved in US

Tecfidera (BG12) has been approved by the FDA, the American drug regulator, making it the third oral disease modifying drug for relapsing MS to be licensed in the USA after fingolimod (Gilenya) and teriflunomide (Aubagio). FDA National MS Society (USA) MedPage Today BG12 (Tecfidera) - drugs in development
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news